CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Dyspepsia - unidentified cause - Management
View full scenario
Definitions
- Dyspepsia is upper abdominal discomfort or pain which may be described as a burning sensation, a heaviness, or an ache. It is often related to eating and may be accompanied by other symptoms such as nausea, fullness in the upper abdomen, or belching.
- Alarm features include one or more of the following:
- Chronic gastrointestinal bleeding.
- Progressive unintentional weight loss.
- Progressive difficulty swallowing.
- Persistent vomiting.
- Iron deficiency anaemia.
- Epigastric mass.
- Suspicion of gastric cancer after investigation with a barium meal.
- Age 55 years or more, presenting with unexplained and persistent recent-onset dyspepsia.
How do I manage dyspepsia in someone with alarm features?
- For people with dyspepsia and significant acute gastrointestinal bleeding arrange immediate admission to hospital.
- For all other people with dyspepsia and alarm features:
- Arrange endoscopy within 14 days and do a full blood count.
- Suspend nonsteroidal anti-inflammatory drugs while awaiting referral. Offer alternative analgesics (e.g. paracetamol and/or opioids).
- The management of other drugs will depend on clinical judgement of the benefits and risks of continued treatment. When there is uncertainty seek specialist advice. Management options include:
- Stopping the drug.
- Reducing the frequency or dose of the drug.
- Substituting the drug for one less likely to cause bleeding or dyspepsia.
- Review and manage lifestyle factors known to exacerbate dyspepsia.
- Prescribe either an alginate or an antacid to relieve dyspepsia whilst awaiting endoscopy. Ensure that proton pump inhibitors or H2-receptor antagonists (including those obtained over-the-counter) are not used, for a minimum of 2 weeks, before endoscopy.
- Advise those people who deteriorate significantly to seek medical attention.
In depth
What lifestyle advice should I give to people with dyspepsia?
- Advise people with dyspepsia that symptoms may improve if they lose weight (if they are overweight), stop or reduce smoking (if they are a smoker), stop or reduce alcohol consumption, and reduce intake of any food or drink associated with worsening symptoms.
- Advise people with reflux symptoms when lying down to avoid having meals within 3–4 hours of going to bed, and to raise the height of the head of the bed by a few inches.
In depth
Prescriptions
Alginates
Age from 16 years onwards
Acidex® suspension (sugar free): aniseed flavour
Acidex liquid aniseed
Take two to four 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Gaviscon® Advance liquid (sugar-free): aniseed flavour
Gaviscon Advance liquid original
Take one to two 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Gaviscon® Advance liquid (sugar-free): peppermint flavour
Gaviscon Advance liquid peppermint
Take one to two 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Gaviscon® Advance tablets (sugar-free): peppermint flavour
Gaviscon Advance chewable tablets
Chew one to two tablets (followed by water) after meals and at bedtime, when required to relieve dyspepsia.
Supply 60 tablets.
Peptac® liquid (sugar-free): aniseed flavour
Peptac liquid aniseed
Take two to four 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Peptac® liquid (sugar-free): peppermint flavour
Peptac liquid peppermint
Take two to four 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Rennie Duo® suspension (sugar-free)
Rennie Duo oral suspension
Take two to four 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Gastrocote® liquid (sugar free)
Gastrocote liquid
Take one to three 5ml spoonfuls four times a day (after meals and at bedtime) when required to relieve dyspepsia.
Supply 500 ml.
Gastrocote® chewable tablets
Gastrocote chewable tablets
Chew one to two tablets (followed by water) up to four times a day after meals and at bedtime, when required to relieve dyspepsia.
Supply 100 tablets.
Topal chewable tablets
Chew one to three tablets (followed by water) four times a day (after meals and at bedtime) when required to relieve dyspepsia.
Supply 42 tablets.
Antacids
Age from 16 years onwards
Co-magaldrox 195/220 suspension
Co-magaldrox 195mg/220mg/5ml oral suspension sugar free
Take two to four 5ml spoonfuls 20-60 minutes after food and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Hydrotalcite 500mg/5ml suspension
Hydrotalcite 500mg/5ml oral suspension
Take two 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Magnesium trisilicate oral suspension
Magnesium trisilicate oral suspension
Take two 5ml spoonfuls (mixed in water) three times a day when required to relieve dyspepsia.
Supply 500 ml.
Antacid with simeticone: Asilone® suspension
Asilone suspension
Take two 5ml spoonfuls after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Antacid with simeticone: Altacite Plus®
Altacite Plus suspension
Take two 5ml spoonfuls up to four times a day after meals and at bedtime, when required to relieve dyspepsia.
Supply 500 ml.
Antacid with simeticone: Maalox Plus® suspension
Maalox Plus suspension
Take one to two 5ml spoonfuls four times a day (between meals and at bedtime) when required to relieve dyspepsia.
Supply 500 ml.
© NHS Institute for Innovation and Improvement